Pilot Study Combining Temozolomide, Oncovin, Camptosar and Oral Antibiotic in Children and Adolescents With Recurrent Malignancy
PHASE1CompletedINTERVENTIONAL
Enrollment
40
Participants
Timeline
Start Date
September 30, 2004
Primary Completion Date
December 31, 2007
Study Completion Date
December 31, 2007
Conditions
LymphomasTumors
Interventions
DRUG
Irinotecan
Trial Locations (1)
73104
Oklahoma University Health Sciences Center-Jimmy Everest Center, Oklahoma City
All Listed Sponsors
lead
University of Oklahoma
OTHER
NCT00222443 - Pilot Study Combining Temozolomide, Oncovin, Camptosar and Oral Antibiotic in Children and Adolescents With Recurrent Malignancy | Biotech Hunter | Biotech Hunter